Death Reported In Phase II Trial For Astellas/FibroGen’s Oral EPO Candidate

Announcement comes just ahead of an FDA advisory committee meeting to discuss EPO products.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet